Skip to main content
TipRanks
Go Ultimate75% OFF

Clinuvel Pharmaceuticals (UR9) Q2 2026 Earnings Report

2 Followers

DE:UR9 Q2 2026 EPS Results

Actual EPS
EUR 0.13
Consensus EPS
EUR 0.18
Beat/Miss
Missed by -EUR 0.05
One Year Ago EPS
EUR 0.17

DE:UR9 Q2 2026 Revenue Results

Actual Revenue
EUR 22.79M
Expected Revenue
EUR 23.00M
Beat/Miss
Missed by -EUR 207.66K
YoY Revenue Growth
+3.60%

Earnings Announcement Details

Quarter
Q2 2026
Date
02/25/2026
Time
After Close
Conference Call
Wednesday, February 25, 2026
DE:UR9 Upcoming Earnings

Clinuvel Pharmaceuticals 's next earnings date is estimated for February 23, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

DE:UR9 Q2 2026 Earnings Call
0:00 / 0:00

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:UR9 Earnings History

DE:UR9 earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 23, 20272027 (Q2)0.15-0.13――
Aug 27, 20262026 (Q4)0.310.290.277.06% (+0.02)
Feb 25, 20262026 (Q2)0.180.130.17-26.43% (-0.05)
Aug 27, 20252025 (Q4)0.170.270.3-11.13% (-0.03)
Feb 26, 20252025 (Q2)0.130.170.1332.08% (+0.04)
Aug 29, 20242024 (Q4)0.270.300.2330.34% (+0.07)
Feb 21, 20242024 (Q2)0.160.130.14-3.64% (-0.00)
Aug 29, 20232023 (Q4)0.230.230.1924.67% (+0.05)
Feb 22, 20232023 (Q2)0.190.140.0792.98% (+0.07)
Aug 30, 20222022 (Q4)0.270.190.22-14.85% (-0.03)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed